Viewing Study NCT03105102

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-03-05 @ 6:29 PM
Study NCT ID: NCT03105102
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-14
First Post: 2017-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Sponsor: AbbVie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Risankizumab View
None ABBV-066 View
None BI 655066 View
None SKYRIZI View
None Crohn's Disease (CD) View